These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 10609527

  • 1. Visceral leishmaniasis in clinical practice.
    Davidson RN.
    J Infect; 1999 Sep; 39(2):112-6. PubMed ID: 10609527
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy of leishmaniasis in India.
    Thakur CP.
    Indian J Pediatr; 1987 Sep; 54(1):7-10. PubMed ID: 3030933
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Visceral leishmaniasis in paediatrics.
    Kafetzis DA, Maltezou HC.
    Curr Opin Infect Dis; 2002 Jun; 15(3):289-94. PubMed ID: 12015464
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
    Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498
    [Abstract] [Full Text] [Related]

  • 8. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
    Minodier P, Retornaz K, Horelt A, Garnier JM.
    Fundam Clin Pharmacol; 2003 Apr; 17(2):183-8. PubMed ID: 12667228
    [Abstract] [Full Text] [Related]

  • 9. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M, Bitnun A, Shaked P, Waldman E, Zilberstein D.
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I, Rougier S, Dugas B, Pino P, Mazier D, Woehrlé F.
    Vet Parasitol; 2006 Jan 30; 135(2):137-46. PubMed ID: 16242844
    [Abstract] [Full Text] [Related]

  • 12. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J, Alvar J, Polo RM, González-Lahoz JM.
    Am J Med; 1988 Jul 30; 85(1):128. PubMed ID: 3389377
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of visceral leishmaniasis in children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2007 Feb 30; 67(1):73-8. PubMed ID: 17506279
    [Abstract] [Full Text] [Related]

  • 14. The chemotherapy of protozoal infections: whither?
    Steck EA.
    J Protozool; 1981 Feb 30; 28(1):30-5. PubMed ID: 6265632
    [No Abstract] [Full Text] [Related]

  • 15. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
    Gramiccia M, Gradoni L, Orsini S.
    Ann Trop Med Parasitol; 1992 Dec 30; 86(6):613-20. PubMed ID: 1304703
    [Abstract] [Full Text] [Related]

  • 16. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, Dedet JP, Campino L, Cañavate C, Dujardin JC.
    Trop Med Int Health; 2008 Oct 30; 13(10):1272-6. PubMed ID: 18764817
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of infantile visceral leishmaniasis].
    Minodier P, Faraut-Gambarelli F, Piarroux R, Gire C, Garnier JM, Dumon H.
    Arch Pediatr; 1999 Jan 30; 6(1):59-66. PubMed ID: 9974099
    [Abstract] [Full Text] [Related]

  • 18. [Visceral leishmaniasis: new drugs].
    Minodier P, Robert S, Retornaz K, Garnier JM.
    Arch Pediatr; 2003 Dec 30; 10 Suppl 5():550s-556s. PubMed ID: 15022780
    [Abstract] [Full Text] [Related]

  • 19. Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
    Berhe N, Ali A, Hailu A, Yeneneh H.
    Acta Trop; 1994 Jun 30; 57(1):83-90. PubMed ID: 7942358
    [Abstract] [Full Text] [Related]

  • 20. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
    Mandal G, Mandal S, Sharma M, Charret KS, Papadopoulou B, Bhattacharjee H, Mukhopadhyay R.
    PLoS Negl Trop Dis; 2015 Feb 30; 9(2):e0003500. PubMed ID: 25714343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.